Interventional Cardiology Devices – Market Insights – United States

The US IC device market is facing intense pricing pressure on established products, such as DES, limiting the overall market growth. However, steady uptake of novel, premium technologies has supported the IC device space and will continue to do so over the forecast period. Additionally, newer technologies that could improve patient outcomes are poised to enter the market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in the US, with market projections from 2019 through 2032.

The coronary stent market is a highly competitive space, with the leading companies continuing to launch updates to their flagship devices.

What are the market share dynamics among the three major competitors in the highly lucrative DES device market?

What competitive strategies are the major companies implementing to gain market share in this market, and how are ASPs being impacted by the strong competition?

What is the developmental pipeline for the next generation of BRS and which technologies are companies utilizing as a stopgap until BRS technology is ready for patient use?

New technologies are changing the way complex PCIs are diagnosed and treated.

What is the impact of the latest generation of alternative coronary physiology modalities, such imaging-based FFR_angio and FFR_CT, on existing intravascular imaging technologies, including traditional FFR and IVUS?

What is the expected impact of emerging balloon-based technologies such as DCBs?

How are new clinical trials impacting IC device segments, procedures, competitors, and products?

The introduction of intravascular lithotripsy has revolutionized the treatment of calcified coronary lesions and vessel preparation prior to stenting.

How has the commercialization of coronary lithotripsy impacted the use of other products used in the interventional cardiology space?

How is reimbursement changing for coronary lithotripsy, and how will this affect adoption of this technology?

Table of contents

Interventional Cardiology Devices - Market Insights - United States

Raihan Jiwa

Raihan Jiwa is an analyst on the Cardiovascular Medtech Insights team at Clarivate. Raihan graduated from Western University with an Honors Specialization in Synthetic Biology. Raihan’s interest lies in the MedTech space as well as in the future of genetic engineering and development of healthcare systems in developing economies.

Contact sales Login to access report

Back to all Medtech Insights reports